GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Gross Margin %

3D Global Biotech (ROCO:6808) Gross Margin % : 75.60% (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. 3D Global Biotech's Gross Profit for the six months ended in Jun. 2024 was NT$33.01 Mil. 3D Global Biotech's Revenue for the six months ended in Jun. 2024 was NT$43.67 Mil. Therefore, 3D Global Biotech's Gross Margin % for the quarter that ended in Jun. 2024 was 75.60%.

Warning Sign:

3D Global Biotech Inc gross margin has been in long-term decline. The average rate of decline per year is -7.4%.


The historical rank and industry rank for 3D Global Biotech's Gross Margin % or its related term are showing as below:

ROCO:6808' s Gross Margin % Range Over the Past 10 Years
Min: 16.28   Med: 24.07   Max: 64.12
Current: 64.12


During the past 7 years, the highest Gross Margin % of 3D Global Biotech was 64.12%. The lowest was 16.28%. And the median was 24.07%.

ROCO:6808's Gross Margin % is ranked better than
54.17% of 744 companies
in the Biotechnology industry
Industry Median: 60.605 vs ROCO:6808: 64.12

3D Global Biotech had a gross margin of 75.60% for the quarter that ended in Jun. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for 3D Global Biotech was -7.40% per year.


3D Global Biotech Gross Margin % Historical Data

The historical data trend for 3D Global Biotech's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Gross Margin % Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 43.59 37.49 16.28 19.91 25.56

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.80 15.63 31.96 20.46 75.60

Competitive Comparison of 3D Global Biotech's Gross Margin %

For the Biotechnology subindustry, 3D Global Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3D Global Biotech's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's Gross Margin % falls into.



3D Global Biotech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

3D Global Biotech's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=5.3 / 20.633
=(Revenue - Cost of Goods Sold) / Revenue
=(20.633 - 15.359) / 20.633
=25.56 %

3D Global Biotech's Gross Margin for the quarter that ended in Jun. 2024 is calculated as


Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=33 / 43.665
=(Revenue - Cost of Goods Sold) / Revenue
=(43.665 - 10.654) / 43.665
=75.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


3D Global Biotech  (ROCO:6808) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

3D Global Biotech had a gross margin of 75.60% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


3D Global Biotech Gross Margin % Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


3D Global Biotech Business Description

Traded in Other Exchanges
N/A
Address
No.99, Section 1, Xintai 5th Road, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech Headlines

No Headlines